Bienvenido a Med Info Alert, el servicio de literatura científica de Boehringer Ingelheim que te permite estar al día de las publicaciones más recientes y relevantes sobre la enfermedad pulmonar intersticial difusa (EPID).
Si estás interesado en recibir alguna publicación de este mes, a continuación, puedes descargarla o acceder a tu cuenta para solicitarla.
¿También quieres estar actualizado los próximos meses con las publicaciones más recientes sobre EPID? Regístrate en avances en fibrosis pulmonar.
Chandel A, et al. External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis. ERJ Open Res. 2023
Reynolds CJ, et al. The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study. Eur Respir J. 2023
Nili M, et al. Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. BMC Pulm Med. 2023
Siebert JN, et al. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study. BMC Pulm Med. 2023
Allanore Y, et al; SENSCIS trial investigators. Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease. Rheumatology (Oxford). 2023
Volkmann ER, et al; SENSCIS trial investigators. Risk of malnutrition in patients with systemic sclerosis-associated interstitial lung disease treated with nintedanib. Arthritis Care Res (Hoboken). 2023
Zanatta E, et al. CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies. Diagnostics (Basel). 2023
Cerro-Chiang G, et al. Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease. Sci Rep. 2023
Wang Q, et al. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis. Chin Med J (Engl). 2023
PC-ES-111278